MedTrace Logo

Madrid Project on the Management of Chronic Obstructive Pulmonary Disease With Home Telemonitoring

NCT02499068 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 237

Last updated 2019-08-06

No results posted yet for this study

Summary

The purpose of the study is to verify the clinical effectiveness of a managed home telemonitoring program in patients with severe COPD against usual clinical practice, as measured by the decrease in the number of exacerbations, number of hospitalizations, hospital days and emergency room visits in a 12 month period

The primary endpoint of effectiveness is "severe exacerbations avoided."

The main hypothesis is that patients with severe or very severe COPD patients managed with a home telehealth program have better outcomes than patients managed according to usual clinical practice.

Conditions

  • COPD
  • Disease Progression

Interventions

DEVICE

Telehealth

Monitoring devices installed at patients home and patients are monitored on a daily bases for early detection of exacerbations and prompt clinical intervention.and being follow-up on a daily bases for early detection and prompt intervention.

Sponsors & Collaborators

  • Linde Health Care

    collaborator OTHER

  • Técnicas Avanzadas de Investigación en Servicios de Salud TAISS

    collaborator UNKNOWN

  • Syreon Corporation

    collaborator INDUSTRY

  • Arturo Garcia

    lead OTHER

Principal Investigators

  • Julio Ancochea Bermúdez, MD, PhD · Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2016-06-01
Completion
2016-06-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02499068 on ClinicalTrials.gov